Exondys 51 Injection
Product Images NDC 60923-363

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Exondys 51 (NDC 60923-363). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Sarepta Therapeutics, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structure And Base Sequence Of Eteplirsen (Exo00 0025 01)

Chemical structure diagram of eteplirsen, the active ingredient in Exondys 51 injection. The image shows four oligonucleotide sequences with indicated breaks, nucleotide bases (A, C, G, T), and their chemical structures. It also includes base structures and the nucleotide sequence from 5' to 3' ends.*

FDA Label Image

Exondys 51 Logo (Exo00 0025 02)

FDA Label Image

Principal Display Panel – 100 mg/2 mL Carton Label (Exo00 0025 03)

Packaging label for Exondys 51 (eteplirsen) Injection 100 mg/2 mL (50 mg/mL) for intravenous infusion after dilution. The label specifies single-dose vials and usage instructions including use of a 0.2 micron in-line filter during infusion. It shows storage conditions at 2°C-8°C, manufacturer Sarepta Therapeutics, and active ingredients per 2 mL vial including eteplirsen and various salts.*

FDA Label Image

Principal Display Panel – 100 mg/2 mL Vial Label (Exo00 0025 04)

Exondys 51 (eteplirsen) Injection, 100 mg/2 mL (50 mg/mL) single dose vial label. The label indicates the product is manufactured for Sarepta Therapeutics, Inc., Cambridge, MA 02142 USA. It includes a barcode, NDC 60923-363-02, and space for lot number and expiration date.*

FDA Label Image

Principal Display Panel – 500 mg/10 mL Carton Label (Exo00 0025 05)

Exondys 51 (eteplirsen) Injection 500 mg/10 mL (50 mg/mL) carton label for intravenous infusion after dilution. The carton states single dose, one vial per carton, and includes storage instructions to refrigerate at 2-8°C, do not freeze, and protect from light. It is manufactured by Sarepta Therapeutics, Inc., Cambridge, MA. The label lists vial contents and additional ingredients, with warnings to discard unused contents and use a 0.2 micron in-line filter during infusion.*

FDA Label Image

Principal Display Panel – 500 mg/10 mL Vial Label (Exo00 0025 06)

Label for Exondys 51 (eteplirsen) Injection 500 mg/10 mL (50 mg/mL), a single-dose intravenous infusion. The label includes storage instructions to refrigerate at 2°C-8°C (36°F-46°F) after dilution. Manufactured for Sarepta Therapeutics, Inc., Cambridge, MA. The label also displays the NDC: 60923-284-10.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.